{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:56:40Z","timestamp":1784357800143,"version":"3.55.0"},"reference-count":21,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2020,2,25]]},"DOI":"10.1253\/circj.cj-19-0986","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T17:06:48Z","timestamp":1581095208000},"page":"456-462","source":"Crossref","is-referenced-by-count":8,"title":["Lifestyle Modification or Medication to Improve Condition of Patients With Asymptomatic Heart Failure\u3000\u2015 Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization II (MOMOTARO II) Study \u2015"],"prefix":"10.1253","volume":"84","author":[{"given":"Akihito","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kurashiki Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinpei","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukuyama City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Hospital Organization Iwakuni Clinical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kagawa Prefectural Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukuyama Cardiovascular Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics \u2013 2012 update: A report from the American Heart Association [Correction]. <i>Circulation<\/i> 2012; 125: E1002."},{"key":"2","unstructured":"2. Lewin J, Ledwidge M, O\u2019Loughlin C, McNally C, McDonald K. Clinical deterioration in established heart failure: What is the value of BNP and weight gain in aiding diagnosis? <i>Eur J Heart Fail<\/i> 2005; 7: 953\u2013957."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Boehm M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: The Telemedical Interventional Monitoring in Heart Failure study. <i>Circulation<\/i> 2011; 123: 1873\u20131880.","DOI":"10.1161\/CIRCULATIONAHA.111.018473"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhang J, Goode KM, Cuddihy PE, Cleland JG; TEN-HMS Investigators. Predicting hospitalization due to worsening heart failure using daily weight measurement: Analysis of the Trans-European Network-Home-Care Management System (TEN-HMS) study. <i>Eur J Heart Fail<\/i> 2009; 11: 420\u2013427.","DOI":"10.1093\/eurjhf\/hfp033"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure: Correlation with fluid status and feasibility of early warning preceding hospitalization. <i>Circulation<\/i> 2005; 112: 841\u2013848.","DOI":"10.1161\/CIRCULATIONAHA.104.492207"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vanderheyden M, Houben R, Verstreken S, Stahlberg M, Reiters P, Kessels R, et al. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure. <i>Circ Heart Fail<\/i> 2010; 3: 370\u2013377.","DOI":"10.1161\/CIRCHEARTFAILURE.109.867549"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nishii N, Kubo M, Okamoto Y, Fujii S, Watanabe A, Toyama Y, et al. Decreased intrathoracic impedance associated with OptiVol Alert can diagnose increased B-type natriuretic peptide: MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) study. <i>Circ J<\/i> 2015; 79: 1315\u20131322.","DOI":"10.1253\/circj.CJ-15-0076"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, et al. Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. <i>Circ Heart Fail<\/i> 2014; 7: 935\u2013944.","DOI":"10.1161\/CIRCHEARTFAILURE.113.001229"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. <i>Eur Heart J<\/i> 2016; 37: 2129\u20132200.","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. <i>Am J Cardiol<\/i> 2006; 97: 1759\u20131764.","DOI":"10.1016\/j.amjcard.2005.12.072"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Cos\u00edn J, D\u00edez J, investigators T. Torasemide in chronic heart failure: Results of the TORIC study. <i>Eur J Heart Fail<\/i> 2002; 4: 507\u2013513.","DOI":"10.1016\/S1388-9842(02)00122-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). <i>J Am Coll Cardiol<\/i> 2003; 42: 705\u2013708.","DOI":"10.1016\/S0735-1097(03)00765-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ahmed A, Husain A, Love TE, Gambassi G, Dell\u2019Italia LJ, Francis GS, et al. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: An observational study using propensity score methods. <i>Eur Heart J<\/i> 2006; 27: 1431\u20131439.","DOI":"10.1093\/eurheartj\/ehi890"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. <i>Br Heart J<\/i> 1987; 57: 17\u201322.","DOI":"10.1136\/hrt.57.1.17"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mebazaa A, Gheorghiade M, Pi\u00f1a IL, Harjola VP, Hollenberg SM, Follath F, et al. Practical recommendations for prehospital and early in-hospital management of patients presenting with acute heart failure syndromes. <i>Crit Care Med<\/i> 2008; 36: S129\u2013S139.","DOI":"10.1097\/01.CCM.0000296274.51933.4C"},{"key":"16","unstructured":"16. Sharpe DN, Coxon R. Nitroglycerin in a transdermal therapeutic system in chronic heart failure. <i>J Cardiovasc Pharmacol<\/i> 1984; 6: 76\u201382."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, et al. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. <i>Pacing Clin Electrophysiol<\/i> 2009; 32: 363\u2013370.","DOI":"10.1111\/j.1540-8159.2008.02245.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. <i>Circulation<\/i> 2011; 124: 1719\u20131726.","DOI":"10.1161\/CIRCULATIONAHA.111.043042"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bohm M, Drexler H, Oswald H, Rybak K, Bosch R, Butter C, et al. Fluid status telemedicine alerts for heart failure: A randomized controlled trial. <i>Eur Heart J<\/i> 2016; 37: 3154\u20133163.","DOI":"10.1093\/eurheartj\/ehw099"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, et al. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. <i>Circulation<\/i> 2002; 105: 1348\u20131353.","DOI":"10.1161\/hc1102.105264"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): A randomised controlled trial. <i>Lancet<\/i> 2014; 384: 583\u2013590.","DOI":"10.1016\/S0140-6736(14)61176-4"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0986\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T22:21:28Z","timestamp":1582928488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/84\/3\/84_CJ-19-0986\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-19-0986","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]}}}